We estimate the penetrance of LQTS for SCN5A W156X around
2% and the Brugada syndrome penetrance around
30%. SCN5A W156X was found in a total of
3 carriers in 8 papers and/or in gnomAD:
2 had Brugada syndrome, 0 had LQTS.
W156X is not present in gnomAD.
W156X has been functionally characterized in 8 papers.
This residue is located in a Non_Hotspot region for Brugada syndrome and a Non_Hotspot
region for LQTS.
In silico predictions, functional data (if available), and location in structure are equivalent to phenotyping
10 individuals for Brugada syndrome (1 diagnosed with Brugada syndrome) and 5 individuals for LQTS (0
with LQTS). These data combined with observations of carriers lead us to estimate the LQTS penetrance for SCN5A
W156X around 2% (0/13)
and the Brugada syndrome penetrance around 30%
(3/13).
In Silico Data
PROVEAN
PolyPhen-2
BLAST-PSSM
REVEL
Penetrance Density BrS (%)
Penetrance Density LQT3 (%)
NA
NA
NA
None
6
0
PROVEAN scores less than -2 are considered deleterious. REVEL scores higher than 0.5 or 0.75 are considered
likely pathogenic (higher sensitivity with the former cutoff, higher specificity with the latter cutoff).
A PolyPhen-2 score of 0.85 or greater is considered likely pathogenic.
BLAST-PSSM reflects the evolutionary conservation of residue substitutions, more negative numbers indicate
fewer observations of the specific substitution than is expected. Penetrance Density is our previously published method
to calculate the average BrS/LQTS probability density in a shell of residues surrounding a residue of interest
(Kroncke et al. 2019).
Summary totals might not agree with the literature table because of duplicate patients, which were excluded from the
total counts. We do not distinguish here between multiple missense codons. Missense variants are combined across
degenerate codon substitutions since codon-level data were not consistently available for curation.
Functional Data
Peak and late/persistent current are relative to wildtype (100% being no different from wildtype).
V0.5 act/inact are the voltages at which half of the maximal current is reached during an activation and
inactivation protocol, each is in units of mV and relative to wildtype.